XML 89 R71.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation - Summary of Stock Option Activity (Detail) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Shares, Outstanding at Beginning Balance 1,112,275  
Number of shares, Assumed in reverse recapitalization 32,685  
Number of Shares, Granted 1,071,073  
Number of Shares, Exercised (255,486)  
Number of Shares, Cancelled (17,627)  
Number of Shares, Outstanding at Ending Balance 1,942,920 1,112,275
Number of shares, Vested and expected to vest 1,942,920  
Number of Shares, Exercisable 673,356  
Weighted- Average Exercise Price, Outstanding at Beginning Balance $ 7.5  
Weighted- Average Exercise Price, Assumed in reverse recapitalization 7.56  
Weighted- Average Exercise Price, Granted 17.27  
Weighted- Average Exercise Price, Exercised 6.81  
Weighted- Average Exercise Price, Cancelled 17.63  
Weighted- Average Exercise Price, Outstanding at Ending Balance 12.93 $ 7.5
Weighted- Average Exercise Price, Vested and expected to vest 12.93  
Weighted- Average Exercise Price, Exercisable $ 8.43  
Weighted Average Remaining Contractual Term, Outstanding 8 years 3 months 29 days 6 years 10 months 13 days
Weighted Average Remaining Contractual Term, Vested and expected to vest 8 years 3 months 29 days  
Weighted Average Remaining Contractual Term, Exercisable 7 years 14 days  
Aggregate Intrinsic Value, Outstanding Beginning Balance $ 10,712  
Aggregate Intrinsic Value, Outstanding Ending Balance 12,380 $ 10,712
Aggregate Intrinsic Value, Vested and expected to vest 12,380  
Aggregate Intrinsic Value, Exercisable $ 12,380